These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 19920766)

  • 1. Statin treatment prevents increased cardiovascular and all-cause mortality associated with clarithromycin in patients with stable coronary heart disease.
    Jensen GB; Hilden J; Als-Nielsen B; Damgaard M; Hansen JF; Hansen S; Helø OH; Hildebrandt P; Kastrup J; Kolmos HJ; Kjøller E; Lind I; Nielsen H; Petersen L; Jespersen CM; Gluud C;
    J Cardiovasc Pharmacol; 2010 Feb; 55(2):123-8. PubMed ID: 19920766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clarithromycin for stable coronary heart disease increases all-cause and cardiovascular mortality and cerebrovascular morbidity over 10years in the CLARICOR randomised, blinded clinical trial.
    Winkel P; Hilden J; Hansen JF; Kastrup J; Kolmos HJ; Kjøller E; Jensen GB; Skoog M; Lindschou J; Gluud C;
    Int J Cardiol; 2015 Mar; 182():459-65. PubMed ID: 25602299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative statin therapy is associated with reduced cardiac mortality after coronary artery bypass graft surgery.
    Collard CD; Body SC; Shernan SK; Wang S; Mangano DT; ;
    J Thorac Cardiovasc Surg; 2006 Aug; 132(2):392-400. PubMed ID: 16872968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of heart rate at rest as a predictor of mortality, hospitalization for heart failure, myocardial infarction, and stroke in patients with stable coronary heart disease (Data from the Treating to New Targets [TNT] trial).
    Ho JE; Bittner V; Demicco DA; Breazna A; Deedwania PC; Waters DD
    Am J Cardiol; 2010 Apr; 105(7):905-11. PubMed ID: 20346304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy.
    Silva M; Matthews ML; Jarvis C; Nolan NM; Belliveau P; Malloy M; Gandhi P
    Clin Ther; 2007 Feb; 29(2):253-60. PubMed ID: 17472818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery.
    Pan W; Pintar T; Anton J; Lee VV; Vaughn WK; Collard CD
    Circulation; 2004 Sep; 110(11 Suppl 1):II45-9. PubMed ID: 15364837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term (11-year) statin therapy following percutaneous coronary intervention improves clinical outcome and is not associated with increased malignancy.
    Kasai T; Miyauchi K; Kurata T; Satoh H; Ohta H; Tanimoto K; Kawamura M; Okazaki S; Yokoyama K; Kojima T; Akimoto Y; Daida H
    Int J Cardiol; 2007 Jan; 114(2):210-7. PubMed ID: 16797744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid-lowering effect of preoperative statin therapy on postoperative major adverse cardiac events after coronary artery bypass surgery.
    Thielmann M; Neuhäuser M; Marr A; Jaeger BR; Wendt D; Schuetze B; Kamler M; Massoudy P; Erbel R; Jakob H
    J Thorac Cardiovasc Surg; 2007 Nov; 134(5):1143-9. PubMed ID: 17976441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of preoperative statin therapy on cardiovascular outcomes in patients undergoing infrainguinal vascular surgery.
    Ward RP; Leeper NJ; Kirkpatrick JN; Lang RM; Sorrentino MJ; Williams KA
    Int J Cardiol; 2005 Oct; 104(3):264-8. PubMed ID: 16186054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin therapy is associated with improved outcomes in vascular surgery patients with renal impairment.
    Welten GM; Chonchol M; Hoeks SE; Schouten O; Dunkelgrün M; van Gestel YR; Goei D; Bax JJ; van Domburg RT; Poldermans D
    Am Heart J; 2007 Nov; 154(5):954-61. PubMed ID: 17967603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive therapy and the benefits of atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial: lipid-lowering arm extension.
    Sever PS; Poulter NR; Dahlof B; Wedel H;
    J Hypertens; 2009 May; 27(5):947-54. PubMed ID: 19318984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients using statin treatment within 24 h after admission for ST-elevation acute coronary syndromes had lower mortality than non-users: a report from the first Euro Heart Survey on acute coronary syndromes.
    Lenderink T; Boersma E; Gitt AK; Zeymer U; Wallentin L; Van de Werf F; Hasdai D; Behar S; Simoons ML
    Eur Heart J; 2006 Aug; 27(15):1799-804. PubMed ID: 16820364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative statin therapy is not associated with a reduced incidence of postoperative acute kidney injury after cardiac surgery.
    Argalious M; Xu M; Sun Z; Smedira N; Koch CG
    Anesth Analg; 2010 Aug; 111(2):324-30. PubMed ID: 20375302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy.
    Corrao G; Conti V; Merlino L; Catapano AL; Mancia G
    Clin Ther; 2010 Feb; 32(2):300-10. PubMed ID: 20206788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of efficacy and safety of atorvastatin (80 mg) to simvastatin (20 to 40 mg) in patients aged <65 versus >or=65 years with coronary heart disease (from the Incremental DEcrease through Aggressive Lipid Lowering [IDEAL] study).
    Tikkanen MJ; Holme I; Cater NB; Szarek M; Faergeman O; Kastelein JJ; Olsson AG; Larsen ML; Lindahl C; Pedersen TR;
    Am J Cardiol; 2009 Mar; 103(5):577-82. PubMed ID: 19231315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early effects of statins in patients with coronary artery disease and high C-reactive protein.
    Muhlestein JB; Anderson JL; Horne BD; Carlquist JF; Bair TL; Bunch TJ; Pearson RR;
    Am J Cardiol; 2004 Nov; 94(9):1107-12. PubMed ID: 15518602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effects of statin therapy on survival in hypertensive patients with acute myocardial infarction: data from the RICO survey.
    Sicard P; Zeller M; Dentan G; Laurent Y; Touzery C; L'huillier I; Janin-Manificat L; Lorgis L; Beer JC; Makki H; Rochette L; Cottin Y;
    Am J Hypertens; 2007 Nov; 20(11):1133-9. PubMed ID: 17954357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation of serum total cholesterol, C-reactive protein levels, and statin therapy to survival in heart failure.
    May HT; Muhlestein JB; Carlquist JF; Horne BD; Bair TL; Campbell BA; Kfoury AG; Lyon JL; Kim H; Renlund DG
    Am J Cardiol; 2006 Sep; 98(5):653-8. PubMed ID: 16923455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of the role of statin therapy in reducing myocardial infarction following elective percutaneous coronary intervention.
    Mood GR; Bavry AA; Roukoz H; Bhatt DL
    Am J Cardiol; 2007 Sep; 100(6):919-23. PubMed ID: 17826370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuation of statin treatment and all-cause mortality: a population-based cohort study.
    Shalev V; Chodick G; Silber H; Kokia E; Jan J; Heymann AD
    Arch Intern Med; 2009 Feb; 169(3):260-8. PubMed ID: 19204217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.